Eikon Therapeutics logo

Senior Engineer, Machine Learning - Chemistry - Eikon Therapeutics

View Company Profile
Job Title
Senior Engineer, Machine Learning - Chemistry
Job Location
Hayward, CA
Job Description

Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells, thereby unlocking otherwise intractable classes of proteins as drug targets.

Position

As part of Eikon’s diverse team, you will interface with biologists, chemists, microscopists, and optical and automation engineers to design and deploy computational solutions that enable the exploration and quantification of Eikon’s high-content datasets. 

About You 

You are an adventurous, passionate, and creative software engineer eager to apply your talents to empower interdisciplinary scientific exploration, inaugurate a radical drug-discovery paradigm, and ultimately create novel medicines. You will bring to this challenge enthusiasm, high energy, intellectual curiosity, and scientific rigor. 

What You’ll Do 

  • Help define and develop and implement machine learning algorithms to support chemistry and advance our drug discovery programs. 
  • Design and optimize algorithms and models for chemical property prediction, compound screening, and reaction optimization. 
  • Deploy machine learning models into production environments and ensure scalability, reliability, and performance. 
  • Work collaboratively with scientists and engineers to understand tactical needs, prototype, and then productionize software to keep experiments moving forward. 
  • Work on multiple projects simultaneously, developing milestones and deadlines in coordination with the broader company goals. 

Qualifications 

  • Bachelor's with 5 years of relevant experience or a Master’s degree with 3 years of relevant experience in Computer Science, Software Engineering 
  • Strong background in machine learning, statistics, data analysis techniques and chemistry and chemical terms/concepts. 
  • Strong Python programming expertise required 
  • Experience with cheminformatics tools and libraries (e.g., RDKit, Open Babel) for chemical data processing and manipulation 
  • Experience with MLOPs frameworks (e.g. ZenML, Metaflow, MLFlow) preferred 
  • Experience with simulation software like Rosetta, deepchem, graph representation learning, and vector databases preferred 
  • Ability to efficiently investigate and solve problems, from prototype development to production designs 
  • Familiarity with biology and biological terms/concepts at the college freshman level preferred 
  • Ability to efficiently investigate and solve problems, from prototype development to production designs 
  • Excellent verbal and written communication skills 
  • Team-oriented, flexible, able to adapt to rapidly evolving goals and challenges 
  • Enthusiasm for drug discovery essential 

At Eikon, employee compensation also includes bonus and equity compensation, in addition to several generous benefit programs, including:​

  • 401k plan with company matching​
  • Medical (premiums covered by Eikon at 95%), dental and vision insurance (premiums covered by Eikon at 100%)​
  • Mental health and wellness benefits​
  • Weeklong summer and winter holiday shutdowns​
  • Generous paid time off and holiday policies​
  • Life/AD&D Insurance (premiums covered by Eikon at 100%) and optional supplemental employee-paid life/AD&D policies ​
  • Enhanced parental leave benefit​
  • Daily subsidized lunch program when on-site​

The expected salary range for this role is $164,000 to $179,550 depending on skills, competency, and the market demand for your expertise.

Eikon is proud to be an equal opportunity employer and will consider all qualified applicants for employment.

In accordance with the Company’s duty to provide and maintain a safe workplace, the Company requires all employees to be Fully Vaccinated with one of the FDA approved COVID-19 vaccines, which includes those vaccines that have received the FDA’s emergency use authorization. You will be expected to be Fully Vaccinated as of your Start Date. If you believe that you are exempt from this requirement under an applicable law or regulations, including Americans with Disabilities Act and California’s Fair Employment and Housing Act, you will need to contact the Company’s Human Resources group. For purposes of this section, Fully Vaccinated means (i) the completion of the vaccination regimen as approved by the FDA (by way of example, 2 doses of the Pfizer or Moderna vaccine and 1 dose of the Johnson and Johnson vaccine), and (ii) timely receiving booster vaccination, as recommended by the Centers for Disease Control and Prevention.

We are currently not accepting any new third-party agencies or firms at this time. Please do not forward unsolicited agency resumes to our website, employees or Human Resources. Eikon Therapeutics will not pay fees to any third-party agency or firm associated with unsolicited resumes.

Everything You Need, One Platform.

From job listings to startups, investors to funding rounds, and everything in between, Employbl puts the power in your hands. Why wait?

Start your free trial today!


Stay Ahead of the Curve

Sign up for our newsletter to stay informed about the latest startups and trends in the tech market. Let Employbl be your guide to success.

Eikon Therapeutics Headquarters Location

Hayward, CA

View on map

Eikon Therapeutics Company Size

Between 200 - 500 employees

Eikon Therapeutics Founded Year

2019

Eikon Therapeutics Total Amount Raised

$772,000,000

Eikon Therapeutics Funding Rounds

View funding details
  • Series C

    $106,000,000 USD

  • Series B

    $518,000,000 USD

  • Series A

    $148,000,000 USD

Eikon Therapeutics' Industries

Eikon Therapeutics' Tech Stack

Eikon Therapeutics' Investors